Cecal Cancer
Definition
Cecal cancer refers to the occurrence of a malignant (cancerous) tumor in the cecum. The cecum is a part of the large intestine located at the beginning of the colon in the lower right side of the abdomen, where the small intestine (the ileum) connects to the large intestine. Simply put, it is a tumor that originates from the cells of the cecal wall and can invade deeper layers of the bowel and surrounding tissues, or spread to distant organs through the blood and lymphatic systems.
Epidemiology (Prevalence and Risk Factors)
As part of the right colon, cecal cancer accounts for approximately 10 to 15 percent of all colorectal cancers. It is more commonly seen in older adults and is often diagnosed through symptoms such as iron-deficiency anemia or occult gastrointestinal bleeding. Globally, colorectal cancer is the second most common cancer in women and the third in men, with more than 1.9 million new cases reported annually. In Iran, colorectal cancer accounts for about 9 to 10 percent of all cancers and is among the five most common malignancies, with an increasing trend in recent years. The exact share of cecal cancer within these numbers is not precisely known, but most studies report a pattern close to global data.
Etiology (Causes and Disease Mechanisms)
• Genetic factors and family history: Having an affected parent or sibling may increase risk.
• Adenomatous polyps (premalignant polyps), which can develop into cancer over years if not removed.
• Advanced age and lifestyle factors such as high-fat/low-fiber diets, obesity, and physical inactivity.
• Inflammatory bowel disease (e.g., long-standing ulcerative colitis) increases risk.
• Dietary factors and alcohol/tobacco use: Long-term alcohol consumption, smoking, and unhealthy dietary patterns are associated with increased risk.
Pathogenesis (Mechanism of Disease Development)
• The process typically begins with an adenomatous polyp (a small benign growth protruding from the mucosa). Over several years, some of these polyps undergo genetic mutations and transform into cancer cells.
• Over time, cancer cells may invade deeper layers of the intestinal wall, gain access to lymphatic or blood vessels, and spread to nearby lymph nodes or distant organs such as the liver or lungs.
• Some tumors have specific molecular characteristics that influence treatment decisions, including responsiveness to targeted therapies or immunotherapy.
Clinical Presentation
Cecal cancer may present late because the cecum has a relatively large diameter, allowing tumors to grow without causing obstruction. This means symptoms can be subtle.
Common symptoms include:
• Fatigue and weakness due to anemia (often iron-deficiency anemia) — caused by slow, chronic bleeding from the tumor that may not be visible in the stool, leading primarily to iron loss and fatigue.
• Loss of appetite or unexplained weight loss.
• Vague pain or discomfort in the lower right abdomen — sometimes mild in early stages.
• Changes in bowel habits such as diarrhea, constipation, or a sense of incomplete evacuation.
• Visible bleeding (occasionally) or blood in the stool — although in cecal cancer, bleeding may present as dark stools or be undetectable without testing.
• In advanced cases: a palpable mass in the lower right abdomen, signs of bowel obstruction (nausea, vomiting, bloating), or symptoms related to metastases such as liver pain or shortness of breath if the liver or lungs are involved.
Important note: New-onset iron-deficiency anemia in an adult without an obvious cause should prompt evaluation for a gastrointestinal source of bleeding, including colorectal cancer.